We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$8.17B
1-Year Est. Return
68.82%
This Fund
S&P 500
This Quarter
Est. Return
+0.75%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$1.31B
AUM Growth
+$305M
(+30%)
Cap. Flow
+$326M
Cap. Flow
% of AUM
24.94%
Top 10 Holdings %
Top 10 Hldgs %
40.19%
Holding
87
New
20
Increased
35
Reduced
4
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$37.6M |
| 2 |
SGI
Somnigroup International
SGI
|
+$37.3M |
| 3 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$32.2M |
| 4 |
United Parks & Resorts
PRKS
|
+$29.4M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$27.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energizer
ENR
|
+$29.4M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$22.5M |
| 3 |
GSK
GSK
|
+$14.6M |
| 4 |
GameStop
GME
|
+$14.4M |
| 5 |
BJ's Restaurants
BJRI
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.43% |
| 2 | Consumer Discretionary | 25.02% |
| 3 | Miscellaneous | 18.11% |
| 4 | Consumer Staples | 9.24% |
| 5 | Financials | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Tapestry
TPR
$23.5B
| – | – |
-204,000
| Closed | -$9.02M |
|
77
Wayfair
W
$13.7B
| – | – |
-68,000
| Closed | -$5.46M |
|
|
QVCGA
78
DELISTED
QVC Group Inc Series A
QVCGA
| – | – |
-7,251
| Closed | -$8.6M |
|
|
EIGR
79
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| – | – |
-12,800
| Closed | -$5.36M |
|
|
BBBY
80
DELISTED
Bed Bath & Beyond Inc
BBBY
| – | – |
-300,000
| Closed | -$6.6M |
|
|
TMBR
81
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| – | – |
-231
| Closed | -$382K |
|
|
AVEO
82
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| – | – |
-60,000
| Closed | -$1.67M |
|
|
FCSC
83
DELISTED
Fibrocell Science Inc.
FCSC
| – | – |
-122,779
| Closed | -$393K |
|
|
AET
84
DELISTED
Aetna Inc
AET
| – | – |
-64,000
| Closed | -$11.5M |
|
|
ANTH
85
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| – | – |
-768,915
| Closed | -$1.27M |
|
|
SHPG
86
DELISTED
Shire pic
SHPG
| – | – |
-64,000
| Closed | -$9.93M |
|
Similar funds
MWM
BP
FWCM
SC
SFM
EHC
BIM
WF
Armistice Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Armistice Capital held 87 positions worth $1.31B, up 30% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Armistice Capital deployed $326M of net new capital in Q1 2018, opening 20 new positions and adding to 35 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 108,000 shares worth $37.2M.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.
On the sell side, the largest reduction was Vanda Pharmaceuticals, an estimated $1.31M trimmed.
- Armistice Capital's largest Q1 2018 buy was Regeneron Pharmaceuticals: 108,000 shares worth $37.2M.
- Armistice Capital added most to United Therapeutics in Q1 2018, an estimated $23.9M increase.
- Armistice Capital's biggest Q1 2018 reduction was Vanda Pharmaceuticals, cutting an estimated $1.31M.
- Armistice Capital fully exited Energizer in Q1 2018, selling an estimated $29.4M.
- Armistice Capital's ten largest holdings make up 40% of its $1.31B portfolio in Q1 2018.
- Armistice Capital opened 20 new positions and closed 23 in Q1 2018.
- Armistice Capital's portfolio value rose 30% quarter-over-quarter to $1.31B.
Based on Armistice Capital's 13F filing for Q1 2018, filed 15 May 2018.